Select a year 2001 2002 2003 2004    Select a researcher Ernesto Abel-Santos, Ph.D. Christopher F. Basler, Ph.D. Yasmine Belkaid, Ph.D. Keril J. Blight, Ph.D. Peter John Bradley, Ph.D. Michael D. Burkart, Ph.D. Kirk W. Deitsch, Ph.D. Michael S. Diamond, M.D., Ph.D. George Dimopoulos, Ph.D. Philip Ralph Dormitzer, M.D., Ph.D. David A. Fidock, Ph.D. Michael Gale Jr., Ph.D. Danielle A. Garsin, Ph.D. Michael S. Glickman, M.D. Kristin M. Hager, Ph.D. Claudia Hase, Ph.D. Kent Hill, Ph.D. B. Joseph Hinnebusch, Ph.D. Stefan H. I. Kappe, Ph.D. Liming Li, Ph.D. Marc Lipsitch, D.Phil. John D. McKinney, Ph.D. Eleftherios “Terry” Mylonakis, M.D., Ph.D. Karen M. Ottemann, Ph.D. Mary X. D. O’Riordan, Ph.D. Lalita Ramakrishnan, M.D., Ph.D. Pejman Rohani, Ph.D. Michael Jeffrey Root,, M.D., Ph.D. Dirk Schnappinger, Ph.D David S. Schneider, Ph.D. Anita Sil, M.D., Ph.D Neal Silverman, Ph.D. Joseph D. Smith, Ph.D. Marcelo Carlos Sousa, Ph.D. Vanessa Sperandio, Ph.D. Ali A. Sultan, M.D., Ph.D. Heather L. True-Krob, Ph.D. Jatin M. Vyas, M.D., Ph.D. Paula Watnick, M.D., Ph.D. Wolfgang Weninger, M.D. Elizabeth Winzeler, Ph.D. Fitnat Yildiz, Ph.D. Select a project Genetic Determinants of Chloroquine Resistance in Plasmod...C. elegans as a Model Host for Understanding the Ge...Analysis of membrane trafficking events in the regulation ...Antibiotic Resistance in Streptococcus pneumoniae: Transmi...Antigen Processing and Presentation in the Specialized Ent...Bacterial and Host Contributions to the Maintenance of the...Bacterial Regulation of Intracellular Immune SurveillanceBiosynthetic Inhibition of Small Molecule Virulence Factor...Breaking barriers: Defining Environmental and Genetic Fact...Cell-to-cell Signaling in E. coli O157:H7 Pathogene...Characterization of a Pattern Recognition Receptor Family ...Characterization of the NS4B Protein in Hepatitis C VirusControlled Silencing of rpoB and ffh in M. smegmatisCoordinate regulation of M. tuberculosis cell envelope com...Detecting and Overcoming Antibiotic Resistance in BacteriaDissecting malaria vector-pathogen interactions using a Dr...DNA Replication and var gene expression in Plasmodium falc...Emerging Viruses: Interferon-Antagonists and VirulenceEnvironmental factors that modulate biofilm formation dyna...Establishing an Intracellular Niche in Apicomplexan Parasi...Facilitate Prion Research Using C. elegansFunctional Analysis of the Plasmodium GenomeGene expression and function in Plasmodium liver stagesGenetic Analysis of TB Persistence: Identification of New ...Genome-wide Binding Analysis of the Plasmodium falciparum ...Helicobacter pylori: Proteins and Processes that Contribut...Identification of the Bioenergetics Sensor Affecting Virul...Latency, Reactivation and Immunity in Chronic Parasitic Di...Mechanism and Biology of Trypanosome cell motility: contri...Mechanisms of Hepatitis C Virus PersistenceMechanisms of Yersinia pestis transmission and pathogenicityMolecular Analysis of Detoxification of Nitric Oxide in Molecular Mechanisms of Plasmodium Sporozoite PathogenicityNovel Regulators of Biofilm Development by Vibrio choleraePeptide Modulators of Bacterial Cell DifferentiationStructure-based Approach to Rotavirus Vaccine Design and C...Targeting Viral Entry Using the 5-Helix Protein Design Str...The Ecology and Evolution of Disease InterferenceThe Immunology and Neurobiology of West Nile Encephalitis ...The Role of CD4+ Central Memory T Cells in Infl...Use of the Caenorhabditis elegans model of fungal p...Using Drosophila to Elucidate the Mechanisms of Pathogenes... Select an institution Albert Einstein College of Medicine of Yeshiva University Children's Hospital, Boston Cornell University Foundation For Advanced Education In The Sciences Harvard School of Public Health Johns Hopkins University Massachusetts General Hospital Memorial Sloan Kettering Cancer Center Mount Sinai School of Medicine National Institute of Allergy and Infectious Disease, National Institutes of Health Northwestern University Oregon State University Rockefeller University Scripps Research Institute Seattle Biomedical Research Institute Stanford University School of Medicine Thomas Jefferson University Tufts University School of Medicine University of California - Los Angeles University of California - San Diego University of California - San Francisco University of California - Santa Cruz University of Colorado - Boulder University of Georgia Research Foundation, Inc. University of Massachusetts Medical School University of Michigan Medical School University of Notre Dame University of Texas Health Science Center - Houston University of Texas Southwest Medical Center University of Texas Southwestern Medical Center University of Washington School of Medicine Washington University Washington University School of Medicine Weill Medical College of Cornell University Wistar Institute

Please call 301-657-1830 for information about this program.

Description
The objective of the Ellison Medical Foundation New Scholars Program in Global Infectious Disease is to support new investigators of outstanding promise in the basic biological and biomedical sciences relevant to research on molecular and cellular mechanisms of parasitic and infectious diseases that are caused by viral, bacterial, fungal, protozoal or helminthic pathogen of major global public health concern and are relatively neglected in federally funded research. The Global Infectious Disease Program provides awards of up to $50,000 per year for a four year period for successful candidates. The Ellison Medical Foundation was established and is supported by Lawrence J. Ellison to support this research.

Restrictions
New Scholar applications are solicited by invitation only. Invitations for application are sent to the university president and the head of the sponsored research program of invited institutions in November. These will contain instructions for how to access the full nomination package through links on the Applications and Receipt Dates page. Institutions will nominate one candidate. Institutions not currently invited may contact Dr. Richard L. Sprott to discuss an application for inclusion in the program.

Eligibility
These awards are intended for investigators who are in the first three (3) years of their research career following their post-doctoral fellowship experience. As of March 2, 2005, nominees must hold regular full time appointments (tenure or non-tenure) on the faculty of the sponsoring institution and they must not have been in such an appointment, at the sponsoring institution or other institution(s), for more than three years as of July 15, 2005, i.e. the appointment having been made no earlier than July 15, 2002. Time spent in clinical internships, post-doctoral training, residencies, or in work toward board certification does not count as part of the three-year limit.

The Ellison Medical Foundation New Scholars may hold one similar award from a private source concurrently for up to one year (career development or new faculty awards including, but not limited to, Burroughs Wellcome Fund Career Awards in the Biomedical Sciences, Hughes Foundation, Infectious Diseases Society of America, March of Dimes Birth Defects Foundation, Pew Charitable Trust, Searle Scholars). New Scholar Awards will only be made for the full four-year term. If a conflicting award is accepted prior to the New Scholar Award, this must be resolved by either declining The Ellison Medical Foundation award or arranging to terminate the conflicting award within one year.

Evaluation
Nominees for the New Scholars Award are expected to have great promise as potential leaders of research in parasitology and infectious disease, particularly as applied to global health. Each nominee's potential for scientific innovation and leadership will be evaluated by the Scientific Advisory Board, based upon the nominee's research proposal, scientific contributions to date, and the reference statements provided by those who know the nominee and his/her work well. The quality and relevance of the nominee's publications and the importance to parasitology and infectious disease of the nominee's proposed research will be significant factors in the evaluation process. Depending upon the number of nominations submitted and the qualifications of the nominees, at least ten Scholars will be selected.

Terms
Each award will be made for up to $50,000 per year for a four year period. Funding for years two, three and four is contingent upon submission of an acceptable progress report.

Acceptable uses for award funds include salary, other personnel, equipment, supplies, resource acquisition and travel. The scholar's salary costs (including fringe benefits) may not exceed $10,000 per year. Carry-overs in excess of $25,000 must be approved by the Ellison Medical Foundation Scholars Program Office. Not more than 8% of the total award may be deducted for overhead costs.

In the case of applications for support of research involving human subjects or animal subjects, or of research collaborations with foreign institutions, the Foundation will require the following documentation before an award can be made: